Euro vs US Dollar

Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.

Registrieren

LGND Ligand Pharmaceuticals Incorporated

85,05

1,09 (1,30%)

31 Mai 2024 - Geschlossen

Verzögert um 15 Minuten

Form 144/A - Report of proposed sale of securities: [Amend]

Ligand Pharmaceuticals (NASDAQ:LGND)
Historical Stock Chart
Von Mai 2024 bis Jun 2024

Click Here for more Ligand Pharmaceuticals Charts.

Ligand Pharmaceuticals (NASDAQ:LGND)
Historical Stock Chart
Von Jun 2023 bis Jun 2024

Click Here for more Ligand Pharmaceuticals Charts.

News Ligand Pharmaceuticals Incorporated

Form 8-K - Current report
Donnerstag 30 Mai 2024 (3 Tage vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Samstag 18 Mai 2024 (2 Wochen vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Samstag 18 Mai 2024 (2 Wochen vor) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Freitag 17 Mai 2024 (2 Wochen vor) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Donnerstag 16 Mai 2024 (2 Wochen vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Donnerstag 16 Mai 2024 (3 Wochen vor) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Donnerstag 16 Mai 2024 (3 Wochen vor) • Edgar (US Regulatory)

Form 144/A - Report of proposed sale of securities: [Amend]
Mittwoch 15 Mai 2024 (3 Wochen vor) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Mittwoch 15 Mai 2024 (3 Wochen vor) • Edgar (US Regulatory)

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Donnerstag 9 Mai 2024 (3 Wochen vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Donnerstag 7 März 2024 (3 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Mittwoch 6 März 2024 (3 Monate vor) • Edgar (US Regulatory)

Weitere Ligand Pharmaceuticals Incorporated News-Artikel

BNP Paribas Issuance

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen